Endothelium modulated vasorelaxant response of a polypharmaceutical herbal drug (lipotab) and its individual constituents

被引:5
作者
Ashraf, MZ
Khan, MSY
Hameed, HA
Hussain, ME
Fahim, M
机构
[1] Univ Delhi, Dept Physiol, VP Chest Inst, Delhi 110007, India
[2] Jamia Millia Islamia, Ctr Biosci, New Delhi 110025, India
[3] Hamdard Nagar, Jamia Hamdard, New Delhi 110067, India
关键词
endothelium; vascular smooth muscle; Alium sativum; lipotab; Curcuma longa; Nepeta hindoostana;
D O I
10.1016/S0378-8741(98)00226-8
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The present study was undertaken to examine the endothelium modulated effects of polypharmaceutical drug lipotab and its individual ingredients in isolated aortic rings of rat. Endothelium intact and denuded aortic rings were precontracted with phenylephrine 10(-6) M and drugs were added in cumulative manner in concentration ranging from 1 to 50 mu g/ml. The results demonstrated an endothelium-dependent vasorelaxant effect of lipotab and its individual ingredients. with the exception of nicotinic acid. The dose dependent relaxant response of nicotinic acid was not altered significantly in the endothelium-denuded rings, suggesting a direct effect of the drug on the vascular smooth muscle. Vasorelaxant effect of lipotab and its individual constituents suggests the therapeutic potential of these compounds in certain cardiovascular diseases. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 102
页数:6
相关论文
共 20 条
[11]   Antiatherosclerotic effect of Lipotab Forte in cholesterol-fed rabbits [J].
Kumar, SR ;
Pillai, KK ;
Balani, DK ;
Hussain, SZ .
JOURNAL OF ETHNOPHARMACOLOGY, 1998, 59 (03) :125-130
[12]   THIOALLYL COMPOUNDS - POTENT INHIBITORS OF CELL-PROLIFERATION [J].
LEE, ES ;
STEINER, M ;
LIN, R .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1221 (01) :73-77
[13]  
LUSTER TF, 1990, HYPERTENSION PATHOPH, P637
[14]   DIRECT ANTI-ATHEROSCLEROSIS-RELATED EFFECTS OF GARLIC [J].
OREKHOV, AN ;
TERTOV, VV ;
SOBENIN, IA ;
PIVOVAROVA, EM .
ANNALS OF MEDICINE, 1995, 27 (01) :63-65
[15]  
RUBNAYI GM, 1993, J CARDIOVASCULAR RES, V22, P1
[16]  
SABOUNI MH, 1991, J PHARM EXPT THERAPE, V59, P508
[17]  
SIEGEL G, 1992, ADV EXP MED BIOL, V311, P53
[18]  
SIEGEL G, 1991, Z KARDIOL, V80, P9
[19]  
SINHA M, 1972, INDIAN J PHARM, V4, P135
[20]  
SRIVASTAVA R, 1986, ARZNEIMITTEL-FORSCH, V36-1, P715